Find similar content

Source channel @githubtrending · Post #15321 · Dec 9

#go#game_engine#game_engine_2d#game_engine_3d#game_engine_development#game_engine_framework#gameengine#go#golang Kaiju Engine is a fast, modern 2D/3D game engine written in Go and powered by Vulkan, designed for simplicity and high performance. It runs on Windows, Linux, Android, and is working on Mac support. Kaiju offers much faster rendering speeds and lower memory use than popular engines like Unity, making game development quicker and more efficient. It uses Go’s garbage collector to help prevent common programming errors, improving stability. You can write games directly in Go, and the engine supports local AI integration and a flexible UI system using HTML/CSS. Although the editor is still in development, the engine itself is production-ready, offering a powerful tool for developers who want speed and simplicity. https://github.com/KaijuEngine/kaiju

Hashtags

#go #game_engine #game_engine_2d #game_engine_3d #game_engine_development #game_engine_framework #gameengine #golang

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment